Related Experiment Videos
[Lung transplantation--established treatment, uncovered need]
1Lungemedisinsk avdeling, Rikshospitalet, Oslo. oystein.bjortuft@rikshospitalet.no
Summary
Lung transplantation in Norway faces donor lung shortages. Patients with idiopathic pulmonary fibrosis and cystic fibrosis experience higher mortality and need earlier referral and higher waiting list priority.
Area of Science:
- Thoracic surgery
- Transplant immunology
- Pulmonary medicine
Background:
- Lung transplantation has been a treatment for end-stage pulmonary disease in Norway since 1990.
- A growing shortage of donor lungs presents a significant challenge.
Purpose of the Study:
- To evaluate patient assessments for lung transplantation.
- To analyze referral patterns and outcomes for end-stage pulmonary disease patients.
Main Methods:
- A retrospective study of 409 patients (212 men, 197 women) referred between 1990 and 2001.
- Analysis of diagnoses, waiting times, and mortality rates.
Main Results:
- Chronic obstructive pulmonary disease (COPD) was the most frequent diagnosis (45%).
- Mortality rates were significantly higher for idiopathic pulmonary fibrosis (IPF) (63%) and cystic fibrosis (CF) (72%) compared to COPD (26%) and alpha-1-antitrypsin deficiency (21%).
- Waiting times increased, with a total mortality of 41% during assessment and waiting periods.
Conclusions:
- IPF patients require earlier referral to lung transplant programs.
- IPF and CF patients should receive higher priority on the lung transplant waiting list due to higher mortality risks.